文献速递鼻科头颈外科

鼻腔鼻窦鳞状细胞癌眶侵犯的管理:15年经验

Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years' experience.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-11-22

该研究回顾性分析了93例接受放疗(伴或不伴手术)的鼻腔鼻窦鳞状细胞癌眶侵犯患者,按眶侵犯程度分为3级。结果显示手术加放疗患者5年生存率为62.2%,90.3%的病例可实现眼眶保留;Ⅲ级眶侵犯与更差的生存独立相关,但眼外肌或眼球侵犯并非保眼手术的禁忌证。

要点

  • 手术加放疗是眶侵犯鼻腔鼻窦鳞癌的主要治疗方式,5年生存率62.2%。
  • Ⅲ级眶侵犯是预后不良的独立因素,与更短OS、LRFS、PFS和DMFS相关。
  • 眼外肌或眼球侵犯并非保眼手术的绝对禁忌,术前放化疗可助保留眼眶。

核心结论

  • Ⅲ级眶侵犯与最差的生存结局相关,但眼外肌或眼球侵犯并非保眼手术的禁忌证。
  • 术前放化疗可为强烈希望保留眼睛的患者提供希望。

研究设计与样本

  • 回顾性分析过去15年93例接受放疗伴或不伴手术的鼻腔鼻窦鳞状细胞癌眶侵犯患者。
  • 眶侵犯程度分为3级。

主要发现

  • 存活患者中位随访60个月,全组5年总生存率为57.4%。
  • 手术加放疗患者5年生存率为62.2%,90.3%的病例眼眶保留可行。

临床怎么用

  • 对眶侵犯鼻腔鼻窦鳞癌,手术加放疗可实现较高眼眶保留率。
  • 眼外肌或眼球侵犯时仍可考虑保眼手术,但需评估Ⅲ级眶侵犯的预后影响。
  • 术前放化疗可作为希望保眼患者的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study was intended to review our management strategy for sinonasal squamous cell carcinomas (SNSCCs) with orbital invasion and to explore the role of radiotherapy in orbital preservation. METHODS: We retrospectively analyzed 93 SNSCC patients with orbital invasion who underwent radiotherapy with or without surgery over the past 15 years. The degree of orbital invasion was classified into 3 grades. RESULTS: Eighty-eight patients presented with T4 tumors and 36 had grade III orbital invasion. Seventy-two patients received surgery plus radiation and 67 received platinum-based chemotherapy. The median follow-up for surviving patients was 60 months. Five-year overall survival (OS) for the whole group was 57.4%. The patients treated with surgery plus radiation had a 5-year survival rate of 62.2% and orbital preservation was feasible in 90.3% of cases. Twenty-one patients with SNSCCs that extended into the extraocular muscles or eye globe also underwent orbital preservation. Five-year locoregional relapse-free survival (LRFS) was 69.5% for patients treated with orbital preservation and 57.1% for those treated with orbital exenteration, indicating no statistical difference. Five-year survival, 5-year progression-free survival (PFS), and 5-year distant metastasis-free survival (DMFS) were similar between groups. Grade III orbital invasion was independently associated with shorter OS, LRFS, PFS, and DMFS. CONCLUSION: Orbital invasion in grade III was associated with the worst survival outcomes. Invasion of either the extraocular muscles or eye globe is not a contraindication for eye-sparing surgery. Preoperative chemoradiation continues to offer hope to patients with a strong desire to preserve their eyes.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Li R, Tian S, Zhu Y, et al. Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years' experience. Int Forum Allergy Rhinol. 2019. PMID: 31756058. doi:10.1002/alr.22465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。